Small molecule antagonists of chemokine receptors as emerging anti-HIV agents
Author:
Publisher
Informa Healthcare
Subject
Drug Discovery,Pharmacology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/13543776.11.8.1245
Reference25 articles.
1. Mechanisms of Viral Membrane Fusion and Its Inhibition
2. HIV-1 entry – an expanding portal for drug discovery
3. Inhibitors of HIV cellular fusion
4. Current Evidence and Future Directions for Targeting HIV Entry
5. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Heterocyclic N-Oxides - An Emerging Class of Therapeutic Agents;Current Medicinal Chemistry;2015-08-24
2. Therapeutic compounds: patent evaluation of WO2011011652A1;Expert Opinion on Therapeutic Patents;2011-05-09
3. CCR5 Antagonists in HIV;Methods and Principles in Medicinal Chemistry;2011-04-04
4. New Macrocyclic Amines Showing Activity as HIV Entry Inhibitors Against Wild Type and Multi-Drug Resistant Viruses;Molecules;2009-05-22
5. A future perspective on the development of chemokine receptor CXCR4 antagonists;Expert Opinion on Drug Discovery;2008-09-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3